Product correctly added to cart.

No image
No image

LRRK2

LRRK2 inhibitors are compounds that target and inhibit the activity of Leucine-Rich Repeat Kinase 2 (LRRK2), an enzyme involved in several cellular processes, including autophagy, vesicle trafficking, and inflammation. Mutations in the LRRK2 gene are associated with an increased risk of developing Parkinson's disease, making LRRK2 a significant target for neurodegenerative disease research. Inhibitors of LRRK2 are crucial for exploring its role in Parkinson's disease and for developing potential therapeutic strategies. At CymitQuimica, we offer a selection of LRRK2 inhibitors to support your research in neurodegeneration, kinase signaling, and therapeutic development.

Read more
Sort by


See more categories

This search does not contain any category.

products per page. 23 products on this category.

discount label

CCG-1423


Ref: TM-T2014

5mg38.00 €
10mg56.00 €
25mg94.00 €
50mg159.00 €
100mg256.00 €
200mg399.00 €
500mg646.00 €
1mL*10mM (DMSO)55.00 €
Estimated delivery in United States, on Monday 16 Dec 2024
discount label

LRRK2-IN-10


Ref: TM-T79746

25mg1,410.00 €
50mg1,851.00 €
100mg2,337.00 €
Estimated delivery in United States, on Monday 27 Jan 2025
discount label

LRRK2-IN-7


Ref: TM-T73176

1mg226.00 €
5mg563.00 €
10mg900.00 €
25mg1,435.00 €
50mg1,869.00 €
Estimated delivery in United States, on Monday 27 Jan 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".